LAMIRA®, an eFlow® Technology nebulizer, is the only device to deliver Insmed’s ARIKAYCE® Liposomal 590 mg Nebuliser Dispersion in the European Union

LAMIRA®, an eFlow® Technology nebulizer, is the only device to deliver Insmed’s ARIKAYCE® Liposomal 590 mg Nebuliser Dispersion in the European Union

Published

PARI Pharma GmbH announces the issue of the CE declaration of conformity for its optimized eFlow Technology LAMIRA Nebuliser System.
 

Read the press release

Back to overview